LEVEMIR
Live / Registered — Registered and renewed (as of 25 Apr 2024)
What this means for you
Registered since 27 Jan 2004. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Jan 2024).
Record
- Serial number
- 76468735
- Registration number
- 2808088
- Mark type
- Word mark
- Filed
- 07 Nov 2002
- Published for opposition
- 04 Nov 2003
- Registered
- 27 Jan 2004
- Next maintenance due
- 27 Jan 2024
- Attorney of record
- Spencer Beall
Goods and services
- Class 005 — Pharmaceuticals: Anti-diabetic preparations
Owner
- Novo Nordisk A/S, DK-2880 Bagsvaerd, DK
- Novo Nordisk A/S, DK-2880 Bagsvaerd, DK
- Novo Nordisk A/S, DK-2880 Bagsvaerd, DK
Prosecution history
- 25 Apr 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 25 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 25 Apr 2024 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 25 Apr 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 09 Apr 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 09 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 Nov 2023 — TEAS SECTION 8 & 9 RECEIVED
- 27 Jan 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 18 Oct 2018 — CORRECTION UNDER SECTION 7 - PROCESSED
- 17 Oct 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Oct 2018 — TEAS SECTION 7 REQUEST RECEIVED
- 28 Dec 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 28 Dec 2013 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 28 Dec 2013 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 17 Dec 2013 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED